Also known as lymphatic obstruction, lymphedema can be the result of cancer or cancer treatment. Statistics have shown that lymphedema can occur within a few days and up to 30 years after breast cancer treatment. Early awareness and intervention are needed to reduce the impact of breast cancer-related lymphedema (2017), according to a study. An estimated 10 million Americans suffer from lymphedema or related diseases. A retrospective analysis by Brayton and colleagues examining health insurance data from a major national insurer showed that the prevalence of lymphedema in cancer survivors increased from 0.95% in 2007 to 1.24% in 2013.
Access the full report @https://www.databridgemarketresearch.com/reports/global-linfedema-tratamiento-mercado
Global market for lymphedema treatmentFrom US$841.00 million in 2021, it is expected to reach US$1,671.51 million by 2029, growing at a sizeable CAGR of 9.2% over the forecast period 2022-2029. The rise of innovation and technology is also driving the growth of the market. The global market for Lymphedema Treatment is growing during the forecast year due to an increase in market players and the availability of advanced imaging products. In addition, manufacturers engage in R&D activities to bring new products to market.
Increased prevalence of lymphedemaexpected to drive market growth
The high prevalence of the disease would lead to a greater demand for the treatment of lymphedema and therefore research and development for the timely treatment of patients will increase, with resources from public-private organizations and government agencies. It would also ensure patient safety. The aspect would bring positive growth in the market.
Scope of the report and market segmentation
report metrics | details |
forecast period | 2022 y 2029 |
What basis? | 2021 |
historic years | 2020 (Adaptable for 2014 - 2019) |
quantitative units | Sales in millions of US dollars, volumes in units, prices in US dollars |
segments covered | Type of treatment (compression therapy, surgery, drug therapy, laser therapy and others), type (primary lymphedema and secondary lymphedema), affected area (genital, lower limb, upper limb and others), age group (adults and geriatric), type of administration of treatments (oral, injectable and others), end users (hospitals, ambulatory surgical centers, specialized clinics and others), distribution channel (direct auction, pharmacies and others) |
countries covered | US, Canada and Mexico in North America, Germany, France, UK, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea , Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia Pacific (APAC) in Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), Brazil, Argentina and the rest of South America as part of South America |
Market Participants Covered | medi Germany (Germany), PAUL HARTMANN AG (Germany), 3M (USA), Tactile Medical (USA), BIOCOMPRESSION SYSTEMS (USA), Lohmann & Rauscher GmbH & Co. (USA), Lohmann & Rauscher GmbH & Co. (USA). KG (Germany), Fig Afek Ltd. (Israel), ThermoTek (USA), Cardinal Health (USA), Smith+Nephew (Germany), HERANTIS PHARMA Plc (Finland), Huntleigh Healthcare Limited (UK), Avet Pharmaceuticals Inc . (USA) and KOYA MEDICAL (USA). |
Data points covered in the report | In addition to market information such as market capitalization, growth rate, market segments, geographical coverage, market players, and market scenario, the market report prepared by Data Data market research team Bridge provides in-depth expert analysis, patient epidemiology, pipeline analysis, pricing. analysis and regulatory framework |
Segment analysis:
The global Lymphedema Treatment market is segmented into seven notable segments on the basis of treatment type, type, affected area, age group, route of administration, end-user, and distribution channel.
- Based on the type of treatment, the global lymphedema treatment market is segmented into compression therapy, surgery, drug therapy, laser therapy, and others. By 2022, the compression therapy segment will dominate the global lymphedema treatment market with a market share of 66.88% as it effectively controls the symptoms of the disease.
- Based on the type, the global Lymphedema Treatment market is segmented into Secondary Lymphedema and Primary Lymphedema. By 2022, the secondary lymphedema segment is expected to dominate the global lymphedema treatment market with a 78.54% market share, as secondary lymphedema is the most common lymphedema in the population.
- Based on the affected area, the global lymphedema treatment market is segmented into lower extremities, upper extremities, and genitalia. By 2022, the lower extremities segment is expected to dominate the global lymphedema treatment market with a market share of 52.79%, as the lower extremities are most affected by lymphedema.
- Based on the age group, the global lymphedema treatment market is segmented into adults, geriatrics, and pediatrics. By 2022, the adult segment is expected to dominate the global lymphedema treatment market with a market share of 50.68%, as relatively many adults undergo surgeries and treatments that cause lymphedema.
- Based on the route of administration, the global lymphedema treatment market is segmented into oral, injectable, and topical. By 2022, the oral segment is expected to dominate the global lymphedema treatment market with a 51.96% market share, as it is the most effective route of administration with better patient compliance.
- Based on the end user, the global Lymphedema Treatment market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. In 2022, due to the increasing number of patients undergoing lymphedema treatment, the hospital segment is expected to dominate the global lymphedema treatment market with a market share of 52.93%.
The hospital will dominate the end-user segment of global lymphedema treatment Mercado
2022 o The hospital segment is expected to expand its dominance by acquiring more than 53% of the market share. This is due to the growth and expansion of the health sector and the growing demand for critical care by the geriatric population.
- Based on the distribution channel, the global Lymphedema Treatment market is segmented into Pharmacy, Direct Offer, and Other. By 2022, the pharmacy segment is expected to dominate the global lymphedema treatment market with a 52.39% market share, driven by a broader target audience and increased R&D activities.
the pharmacies will dominate the global segment of distribution channels for the treatment of lymphedema Mercado
In 2022, the pharmacy segment is expected to further expand its dominance by acquiring more than 52% market share. This is due to the increasing number of direct offers on the market.
main actors
Data Bridge Market Research recognizes the following companies as major market participants: medi Deutschland (Germany), PAUL HARTMANN AG (Germany), 3M (US), Tactile Medical (US), BIOCOMPRESSION SYSTEMS (US). UU.), Lohmann & Rauscher GmbH & Co. KG (Germany), Fig Afek Ltd. (Israel), ThermoTek (USA), Cardinal Health (USA), Smith+Nephew (Germany), HERANTIS PHARMA Plc (Finland), Huntleigh Healthcare Limited (UK), Avet Pharmaceuticals Inc . (USA) and KOYA MEDICAL (USA).
market development
- In August 2021, AIROS Medical, Inc., Wrist Assist Devices, announced an exclusive partnership for the US distribution agreement for the Wrist Assist fa-1 compression device. This strategic alliance aims to improve the growth rate of the company in the market.
- PAUL HARTMANN AG partnered with Apollo Hospitals Group in India and Western China in September 2020 to shift focus to medical education, wound care clinics and outpatient clinics, products and services. The goal of the association was to expand into the Asia-Pacific region.
- In August 2019, PAUL HARTMANN AG announced the acquisition of Safran Coating from Safran SA. This acquisition helped the company expand its product portfolio.
Regional Analysis
Geographically, the market report covers the US, Canada and Mexico in North America, Germany, France, UK, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan and India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), Brazil, Argentina, and the rest of South America as part of South America.
According to Data Bridge market research analysis:
North America is the dominant region in the treatment of lymphedema Mercadoin the forecast period from 2022 to 2029
In line with the region's rapidly evolving technological advances in the healthcare industry, North America had the largest market share. Furthermore, due to the increased awareness of IgG4-related diseases, there is likely to be great potential for market expansion.
Pacific Asia It is considered the fastest growing region inlymphedema treatment Mercadothe forecast period from 2022 to 2029
During the forecast period, Asia-Pacific is expected to have the largest market share. This expansion can be attributed to an increase in chronic diseases, improvements in healthcare systems, and increased research and development efforts by governments and pharmaceutical companies to develop treatment strategies for lymphedema.
COVID-19 Impact Analysis
The growth of the lymphedema treatment market has been significantly hampered by the coronavirus disease. Academic and research institutions, as well as companies in the healthcare industry, including pharmaceutical and biochemical companies, were severely affected. Hospitals around the world have been focused on treating people infected with the coronavirus. As a result, people suffering from various diseases were negatively affected. The shutdown also caused disruptions to the market and the supply chain.
More information about thelymphedema treatment Mercado Report, click here –https://www.databridgemarketresearch.com/reports/global-linfedema-tratamiento-mercado
FAQs
What is the market for lymphedema treatment? ›
Global Lymphedema Treatment Market Insights
Global lymphedema treatment market size was valued at USD 8.15 billion in 2021, and it is expected to reach a value of USD 11.58 billion by 2028, at a CAGR of 5.1% over the forecast period (2022 -2028).
The lymphedema treatment industry revenue of USD 786.53 Million in 2021 is expected to grow up to USD 1,735.36 Million by 2030.
What is the most effective treatment for lymphedema? ›The recommended treatment for lymphoedema is decongestive lymphatic therapy (DLT). DLT is not a cure for lymphoedema, but it can help control the symptoms. Although it takes time and effort, the treatment can be used to bring lymphoedema under control.
What are the statistics of lymphedema? ›Primary lymphedema is rare, affecting 1 in 100,000 individuals. Secondary lymphedema is the most common cause of the disease and affects approximately 1 in 1000 Americans.
What is the gold standard for lymphedema treatment? ›Complete decongestive therapy (CDT) is the gold standard for lymphedema management.
Will lymphedema ever be cured? ›There's no cure for lymphedema. Treatment focuses on reducing the swelling and preventing complications.
Does Medicare pay for lymphedema machine? ›Pneumatic devices are covered for the treatment of lymphedema or for the treatment of chronic venous insufficiency with venous stasis ulcers.
How long does lymphedema treatment last? ›It can last on average from anywhere from 2-4 weeks or even 8 weeks, depending on how long it takes to reduce the swelling and improve other symptoms affecting the skin. Complete decongestive therapy for one-hour sessions, 4 to 5 days per week.
What percentage of fluid is recovered by the lymphatic system? ›The lymphatic system has three primary functions. First of all, it returns excess interstitial fluid to the blood. Of the fluid that leaves the capillary, about 90 percent is returned. The 10 percent that does not return becomes part of the interstitial fluid that surrounds the tissue cells.
What is the best vitamin for lymphedema? ›Inflammation is by far one of the most outwardly visible symptoms of lymphedema, and there is ample evidence that shows vitamin D deficiency contributes to higher levels of inflammation in the body. Therefore, vitamin D in your system, helps control inflammation.
Does CBD oil help lymphedema? ›
One of the most widely-known effects of CBD is its anti-inflammatory properties. Naturally, this means that any inflammation caused by lymphedema can be reduced using CBD, in addition to relieving area-specific pain or soreness that may be caused by lymphedema.
What is the new treatment for lipedema 2022? ›Tumescent liposuction, which uses a solution injected into the tissue to decrease pain and bleeding, has become a standard procedure in surgical treatment of lipedema.
What is the leading cause of lymphedema in the US? ›The most common causes of lymphedema include: Cancer. If cancer cells block lymph vessels, lymphedema may result. For instance, a tumor growing near a lymph node or lymph vessel could enlarge enough to block the flow of the lymph fluid.
What is the number one cause of lymphedema? ›Primary lymphoedema is caused by alterations (known as mutations) in genes responsible for the development of the lymphatic system (a network of channels and glands distributed throughout the body that help fight infection and remove excess fluid from the body).
What is the mortality rate for lymphedema? ›Median length of stay was 3.61 days and inpatient mortality was 0.03%.
What is new for lymphedema? ›Now, researchers have found that a chemical similar to some glaucoma medicines alleviates symptoms of lymphedema in mice by targeting a specific protein, suggesting a new approach to treating the disease.
What type of therapist treats lymphedema? ›Physical therapists work closely with you and other members of your health care team to help control swelling caused by lymphedema and meet your goals for returning to your activities. Physical therapists are movement experts.
What medical specialty treats lymphedema? ›- Breast and Melanoma Surgical Oncology.
- Breast Clinic.
- Pediatric Rehabilitation.
- Physical Medicine and Rehabilitation.
- Plastic and Reconstructive Surgery.
- Vascular centers.
How much does lymphedema surgery cost? Lymphedema surgery after cancer treatment is considered a reconstructive procedure and should be covered by health insurance. However, your coverage may only provide a portion of the total fee. Be sure to consult with your insurance company in advance of any surgery.